Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.

Franzese C, Fogliata A, Clerici E, Franceschini D, Villa E, D'Agostino G, Navarria P, Mancosu P, Tomatis S, Cozzi L, Scorsetti M.

Radiat Oncol. 2015 Nov 6;10:224. doi: 10.1186/s13014-015-0535-0.

2.

Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure.

Geretschläger A, Bojaxhiu B, Dal Pra A, Leiser D, Schmücking M, Arnold A, Ghadjar P, Aebersold DM.

Radiat Oncol. 2015 Jan 17;10:20. doi: 10.1186/s13014-014-0323-2.

3.

Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.

Merlotti A, Alterio D, Vigna-Taglianti R, Muraglia A, Lastrucci L, Manzo R, Gambaro G, Caspiani O, Miccichè F, Deodato F, Pergolizzi S, Franco P, Corvò R, Russi EG, Sanguineti G; Italian Association of Radiation Oncology.

Radiat Oncol. 2014 Dec 29;9:264. doi: 10.1186/s13014-014-0264-9.

4.

Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer.

Janssen S, Glanzmann C, Huber G, Studer G.

Radiat Oncol. 2014 Jun 13;9:136. doi: 10.1186/1748-717X-9-136.

6.

Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments.

Marcu LG.

Biomed Res Int. 2013;2013:817279. doi: 10.1155/2013/817279. Epub 2013 Dec 19.

7.

The treatment outcome and radiation-induced toxicity for patients with head and neck carcinoma in the IMRT era: a systematic review with dosimetric and clinical parameters.

Kouloulias V, Thalassinou S, Platoni K, Zygogianni A, Kouvaris J, Antypas C, Efstathopoulos E, Nikolaos K.

Biomed Res Int. 2013;2013:401261. doi: 10.1155/2013/401261. Epub 2013 Oct 22.

8.

IMRT and IGRT in head and neck cancer: Have we delivered what we promised?

Tejpal G, Jaiprakash A, Susovan B, Ghosh-Laskar S, Murthy V, Budrukkar A.

Indian J Surg Oncol. 2010 Apr;1(2):166-85. doi: 10.1007/s13193-010-0030-x. Epub 2010 Nov 21.

9.

Feasibility of intensity-modulated and image-guided radiotherapy for functional organ preservation in locally advanced laryngeal cancer.

Nguyen NP, Chi A, Betz M, Almeida F, Vos P, Davis R, Slane B, Ceizyk M, Abraham D, Smith-Raymond L, Stevie M, Jang S, Gelumbauskas S, Vinh-Hung V.

PLoS One. 2012;7(8):e42729. doi: 10.1371/journal.pone.0042729. Epub 2012 Aug 20. Review.

10.

Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.

Bhide SA, Newbold KL, Harrington KJ, Nutting CM.

Br J Radiol. 2012 May;85(1013):487-94. doi: 10.1259/bjr/85942136. Review.

11.

Comparison of acute toxicities in two primary chemoradiation regimens in the treatment of advanced head and neck squamous cell carcinoma.

Fan KY, Gogineni H, Zaboli D, Lake S, Zahurak ML, Best SR, Levine MA, Tang M, Zinreich ES, Saunders JR, Califano JA, Blanco RG, Pai SI, Messing B, Ha PK.

Ann Surg Oncol. 2012 Jun;19(6):1980-7. doi: 10.1245/s10434-012-2219-4.

12.

Successful closure of pharyngo-cutaneous and phayryngo-tracheal fistulas using removable hypopharyngeal stent after laryngectomy for laryngeal carcinoma.

Eloubeidi MA, Morgan DE, Carroll WR, Johnson LF.

Saudi J Gastroenterol. 2012 Jan-Feb;18(1):62-7. doi: 10.4103/1319-3767.91730.

13.
14.

Sparing the contralateral submandibular gland without compromising PTV coverage by using volumetric modulated arc therapy.

Doornaert P, Verbakel WF, Rietveld DH, Slotman BJ, Senan S.

Radiat Oncol. 2011 Jun 16;6:74. doi: 10.1186/1748-717X-6-74.

15.

Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.

Paximadis P, Yoo G, Lin HS, Jacobs J, Sukari A, Dyson G, Christensen M, Kim H.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1515-21. doi: 10.1016/j.ijrobp.2011.04.064. Epub 2011 Jun 12.

16.

Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.

Shukla-Dave A, Lee NY, Jansen JF, Thaler HT, Stambuk HE, Fury MG, Patel SG, Moreira AL, Sherman E, Karimi S, Wang Y, Kraus D, Shah JP, Pfister DG, Koutcher JA.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1837-44. doi: 10.1016/j.ijrobp.2011.03.006. Epub 2011 May 19.

17.

Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience.

Van Gestel D, Van Den Weyngaert D, Schrijvers D, Weyler J, Vermorken JB.

Br J Radiol. 2011 Apr;84(1000):367-74. doi: 10.1259/bjr/67058055.

18.

Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary--an experience in Taiwan.

Chang MF, Wang HM, Kang CJ, Huang SF, Lin CY, Fang KH, Chen EY, Chen IH, Liao CT, Chang JT.

Radiat Oncol. 2010 Oct 7;5:91. doi: 10.1186/1748-717X-5-91.

19.

Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.

Chen L, Hu GF.

Oral Oncol. 2010 Sep;46(9):648-53. doi: 10.1016/j.oraloncology.2010.06.011. Epub 2010 Jul 24. Review.

20.

Concurrent radiochemotherapy in advanced hypopharyngeal cancer.

Krstevska V, Stojkovski I, Lukarski D.

Radiat Oncol. 2010 May 18;5:39. doi: 10.1186/1748-717X-5-39.

Items per page

Supplemental Content

Write to the Help Desk